Search Results

There are 14362 results for: content related to: Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy

  1. Identification of Physiological and Toxic Conformations in Aβ42 Aggregates

    ChemBioChem

    Volume 10, Issue 2, January 26, 2009, Pages: 287–295, Yuichi Masuda, Satoko Uemura, Ryutaro Ohashi, Azusa Nakanishi, K. Takegoshi, Takahiko Shimizu, Takuji Shirasawa and Kazuhiro Irie

    Article first published online : 29 DEC 2008, DOI: 10.1002/cbic.200800411

  2. Distance Measurement between Tyr10 and Met35 in Amyloid β by Site-Directed Spin-Labeling ESR Spectroscopy: Implications for the Stronger Neurotoxicity of Aβ42 than Aβ40

    ChemBioChem

    Volume 8, Issue 18, December 17, 2007, Pages: 2308–2314, Kazuma Murakami, Hideyuki Hara, Yuichi Masuda, Hajime Ohigashi and Kazuhiro Irie

    Article first published online : 19 NOV 2007, DOI: 10.1002/cbic.200700240

  3. Critique of the use of fluorescence-based reporters in Escherichia coli as a screening tool for the identification of peptide inhibitors of Aβ42 aggregation

    Journal of Peptide Science

    Volume 19, Issue 2, February 2013, Pages: 74–83, Oliver Wright, Liao Zhang, Yun Liu, Tatsuya Yoshimi, Yizhi Zheng and Alan Tunnacliffe

    Article first published online : 16 DEC 2012, DOI: 10.1002/psc.2474

  4. β-amyloid peptide is internalized into chick retinal neurons and alters the distribution of myosin Vb

    Cytoskeleton

    Volume 69, Issue 3, March 2012, Pages: 166–178, Leandro T. Oliveira, Priscila A. Matos, David William Provance Jr., Fernando G. de Mello, Leonardo R. Andrade, Martha M. Sorenson and Verônica P. Salerno

    Article first published online : 3 FEB 2012, DOI: 10.1002/cm.21007

  5. You have full text access to this OnlineOpen article
    Discovery of amyloid-beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubility

    Protein Science

    Volume 18, Issue 2, February 2009, Pages: 277–286, Li Ling Lee, HyungHo Ha, Young-Tae Chang and Matthew P. DeLisa

    Article first published online : 15 DEC 2008, DOI: 10.1002/pro.33

  6. You have free access to this content
    The turn formation at positions 22 and 23 in the 42-mer amyloid β peptide: The emerging role in the pathogenesis of Alzheimer's disease

    Geriatrics & Gerontology International

    Volume 10, Issue s1, July 2010, Pages: S169–S179, Kazuma Murakami, Yuichi Masuda, Takuji Shirasawa, Takahiko Shimizu and Kazuhiro Irie

    Article first published online : 2 JUN 2010, DOI: 10.1111/j.1447-0594.2010.00598.x

  7. The immune system, amyloid-β peptide, and Alzheimer's disease

    Immunological Reviews

    Volume 205, Issue 1, June 2005, Pages: 244–256, Marc E. Weksler, Gunnar Gouras, Norman R. Relkin and Paul Szabo

    Article first published online : 9 MAY 2005, DOI: 10.1111/j.0105-2896.2005.00264.x

  8. You have full text access to this OnlineOpen article
    Co-incorporation of Aβ40 and Aβ42 to form mixed pre-fibrillar aggregates

    European Journal of Biochemistry

    Volume 270, Issue 4, February 2003, Pages: 654–663, David Frost, Paul M Gorman, Christopher M. Yip and Avijit Chakrabartty

    Article first published online : 24 JAN 2003, DOI: 10.1046/j.1432-1033.2003.03415.x

  9. You have full text access to this OnlineOpen article
    A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease

    Annals of Neurology

    Eric Karran and John Hardy

    Article first published online : 2 JUL 2014, DOI: 10.1002/ana.24188

  10. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme

    Journal of Neuroscience Research

    Volume 92, Issue 9, September 2014, Pages: 1178–1186, Shuyu Liu, Junjun Liu, Yukie Miura, Chiaki Tanabe, Tomoji Maeda, Yasuo Terayama, Anthony J. Turner, Kun Zou and Hiroto Komano

    Article first published online : 14 MAY 2014, DOI: 10.1002/jnr.23404

  11. You have full text access to this OnlineOpen article
    Amelioration of cognitive deficits in plaque-bearing Alzheimer's disease model mice through selective reduction of nascent soluble Aβ42 without affecting other Aβ pools

    Journal of Neurochemistry

    Volume 125, Issue 3, May 2013, Pages: 465–472, Yasuyuki Mitani, Junko Yarimizu, Hiroki Akashiba, Yoshitsugu Shitaka, Keni Ni and Nobuya Matsuoka

    Article first published online : 8 JAN 2013, DOI: 10.1111/jnc.12125

  12. Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease

    Histopathology

    Volume 38, Issue 2, February 2001, Pages: 120–134, M R D'Andrea, R G Nagele, H-Y Wang, P A Peterson and D H S Lee

    Article first published online : 21 DEC 2001, DOI: 10.1046/j.1365-2559.2001.01082.x

  13. You have full text access to this OnlineOpen article
    Altered γ-secretase activity in mild cognitive impairment and Alzheimer's disease

    EMBO Molecular Medicine

    Volume 4, Issue 4, April 2012, Pages: 344–352, Nobuto Kakuda, Mikio Shoji, Hiroyuki Arai, Katsutoshi Furukawa, Takeshi Ikeuchi, Kohei Akazawa, Mako Takami, Hiroyuki Hatsuta, Shigeo Murayama, Yasuhiro Hashimoto, Masakazu Miyajima, Hajime Arai, Yu Nagashima, Haruyasu Yamaguchi, Ryozo Kuwano, Kazuhiro Nagaike, Yasuo Ihara and the Japanese Alzheimer's Disease Neuroimaging Initiative

    Article first published online : 21 FEB 2012, DOI: 10.1002/emmm.201200214

  14. Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils

    Journal of Neurochemistry

    Volume 126, Issue 3, August 2013, Pages: 305–311, Lei Gu and Zhefeng Guo

    Article first published online : 12 MAR 2013, DOI: 10.1111/jnc.12202

  15. You have full text access to this OnlineOpen article
    Interaction of human and mouse Aβ peptides

    Journal of Neurochemistry

    Volume 91, Issue 6, December 2004, Pages: 1398–1403, Justin Fung, David Frost, Avijit Chakrabartty and JoAnne McLaurin

    Article first published online : 2 DEC 2004, DOI: 10.1111/j.1471-4159.2004.02828.x

  16. You have full text access to this OnlineOpen article
    N-Terminal pyroglutamate formation of Aβ38 and Aβ40 enforces oligomer formation and potency to disrupt hippocampal long-term potentiation

    Journal of Neurochemistry

    Volume 121, Issue 5, June 2012, Pages: 774–784, Dagmar Schlenzig, Raik Rönicke, Holger Cynis, Hans-Henning Ludwig, Eike Scheel, Klaus Reymann, Takaomi Saido, Gerd Hause, Stephan Schilling and Hans-Ulrich Demuth

    Article first published online : 28 MAR 2012, DOI: 10.1111/j.1471-4159.2012.07707.x

  17. β-Amyloid Therapeutic Strategies for Alzheimer's Disease

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Bruno P. Imbimbo and Francesca Speroni

    Published Online : 14 OCT 2005, DOI: 10.1002/0471266949.bmc112

  18. Serum levels of albumin-amyloid beta complexes are decreased in Alzheimer's disease

    Geriatrics & Gerontology International

    Volume 14, Issue 3, July 2014, Pages: 716–723, Keiichi Yamamoto, Hiroyuki Shimada, Hideo Koh, Suzuka Ataka and Takami Miki

    Article first published online : 11 SEP 2013, DOI: 10.1111/ggi.12147

  19. You have full text access to this OnlineOpen article
    Modulation of β-amyloid metabolism by non-steroidal anti-inflammatory drugs in neuronal cell cultures

    Journal of Neurochemistry

    Volume 88, Issue 2, January 2004, Pages: 337–348, Laura Gasparini, Laura Rusconi, Huaxi Xu, Piero Del Soldato and Ennio Ongini

    Article first published online : 23 DEC 2003, DOI: 10.1111/j.1471-4159.2004.02154.x

  20. You have full text access to this OnlineOpen article
    Inhibition of Alzheimer’s amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo

    Journal of Neurochemistry

    Volume 108, Issue 4, February 2009, Pages: 1097–1108, Hyun-Seok Hong, Sandeep Rana, Lydia Barrigan, Aibin Shi, Yi Zhang, Feimeng Zhou, Lee-Way Jin and Duy H. Hua

    Article first published online : 25 DEC 2008, DOI: 10.1111/j.1471-4159.2008.05866.x